Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Modified clostridial toxins with altered targeting capabilities for clostridial toxin target cells

Modified clostridial toxins with altered targeting capabilities for clostridial toxin target cells

US Patent 8460682 · Granted Jun 11, 2013

Estimated economic value: $149,565,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Imidazopyrimidines as EED inhibitors and the use thereof2024
Anti-CD39 antibodies and use thereof2024
Fused 1,4-oxazepines as BET protein degraders2022
Immuno-based botulinum toxin serotype A activity assays2022
Immuno-based botulinum toxin serotype A activity assays2022
BET bromodomain protein degraders with cleavable linkers2022
Immuno-based botulinum toxin serotype A activity assays2022
Immuno-based botulinum toxin serotype A activity assays2022
Fusion proteins comprising a non-cytotoxic protease, a translocation domain, and2022
Fusion proteins comprising a non-cytotoxic protease, a translocation domain, and2022
Microneedle array with active ingredient2021
Botulinum neurotoxin for treatment of disorders associated with melanocyte hyper2021